Lessee, Operating Lease, Liability, to be Paid in USD of Neumora Therapeutics, Inc. from Q4 2023 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Neumora Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q4 2023 to Q4 2024.
  • Neumora Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending December 31, 2024 was $1.89M, a 66.3% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)

Neumora Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $1.89M -$3.72M -66.3% Dec 31, 2024 10-K 2025-03-03
Q4 2023 $5.61M Dec 31, 2023 10-K 2024-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.